MPG.eBooks - Search Results

1

Clinical and economic review report: Vedolizumab (ENTYVIO SC) Takeda Canada Inc. : indication: Crohn disease

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review Clinical and economic review report for Vedolizumab (Entyvio SC)...”

Read Now

2

Robot-assisted surgery compared with open surgery and laparoscopic surgery : clinical effectiveness and economic analyses

by Ho, Chuong
Published 2011

Canadian Agency for Drugs and Technologies in Health

“... procedures and laparoscopic procedures, followed by a systematic review of economic evaluation studies. We...”

Read Now

3

CADTH Canadian Drug Expert Committee recommendation: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza -- Janssen Inc.) : indication: treatment of HIV type 1 (HIV-1...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cobicistat / economics...”

Read Now

4

Effectiveness of factor V leiden and prothrombin mutation testing in patients presenting with a first unprovoked venous thromboembolic episode : a systematic review and economic an...

Published 2015

Canadian Agency for Drugs and Technologies in Health

Read Now

5

Effectiveness of factor V leiden and prothrombin mutation testing in patients presenting with a first unprovoked venous thromboembolic episode : a systematic review and economic an...

Published 2015

Canadian Agency for Drugs and Technologies in Health

Read Now

6

Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses : an economic analysis and budget impact analysis

by Membe, Stephen K.
Published 2011

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Plasma Substitutes / economics...”

Read Now

7

Economic evaluation of unfractionated heparin versus low-molecular-weight heparin to prevent venous...

by Klarenbach, Scott, So, Helen, Manns, Braden, Tonelli, Marcello
Published 2017

Canadian Agency for Drugs and Technologies in Health

“... and economic implications. Given these considerations, the selection of a VTE prevention pharmacologic option...”

Read Now

8

Pharmacoeconomic review report: Brexpiprazole (Rexulti) : (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.) : indication: treatment of schizophrenia in adults

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Thiophenes / economics...”

Read Now

9

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Omalizumab / economics...”

Read Now

10

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Omalizumab / economics...”

Read Now

11

CADTH Canadian Drug Expert Committee recommendation: Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis B.

Published 2018

CADTH

Subjects: “...Antiviral Agents / economics...”

Read Now

12

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...

Published 2018

CADTH

Subjects: “...Immunologic Factors / economics...”

Read Now

13

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ivabradine / economics...”

Read Now

14

CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Pharmaceutical Services / economics...”

Read Now

15

CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Pharmaceutical Services / economics...”

Read Now

16

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ivabradine / economics...”

Read Now

17

Pharmacoeconomic review report: Tiotropium bromide monohydrate (Spiriva respimat) for inhalation

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Tiotropium Bromide / economics...”

Read Now

18

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

19

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

20

Pharmacoeconomic review report: Tiotropium bromide monohydrate (Spiriva respimat) for inhalation

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Tiotropium Bromide / economics...”

Narrow Search